Entera Bio (ENTX) Accounts Payables (2017 - 2026)
Entera Bio (ENTX) posted quarterly Accounts Payables of $274000.0 for Q1 2026, up 104.48% year-on-year from $134000.0 in Q1 2025, and down 38.84% on a QoQ basis from $448000.0 in Q4 2025.
Entera Bio (ENTX) Accounts Payables (2017 - 2026) Analysis & Trends
Entera Bio (ENTX) has reported Accounts Payables for 10 consecutive years, with $274000.0 the latest figure, recorded in Q1 2026.
- Quarterly Accounts Payables rose 104.48% year-over-year to $274000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $274000.0 (up 104.48% YoY) and the FY2025 annual result came in at $448000.0, up 239.39% from the prior year.
- Accounts Payables slipped to $274000.0 in Q1 2026 per ENTX's latest filing, from $448000.0 in the prior quarter.
- Over the last five years, Accounts Payables for ENTX reached as high as $564000.0 in Q3 2023 and fell as low as $17000.0 in Q4 2022.
- A 5-year average of $216529.4 and a median of $184000.0 in 2024 frame the typical range for Accounts Payables.
- Annual changes were most pronounced in 2022 — Accounts Payables plunged 92.6% — and 2025, when it surged 455.07%.
- Year by year, Accounts Payables stood at $17000.0 in 2022, then surged by 388.24% to $83000.0 in 2023, then jumped by 59.04% to $132000.0 in 2024, then soared by 239.39% to $448000.0 in 2025, then sank by 38.84% to $274000.0 in 2026.
- According to Business Quant data, Accounts Payables over the past three periods registered $274000.0, $448000.0, and $216000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 5.74 Mn |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | 10.62 Mn |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 8.64 Mn |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 423.55 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 489.30 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 1.03 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 1.52 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 80.54 Mn |
| 10 | Entera Bio | 186.78 Mn | 182.64 Mn | - | 274,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 274,000.00 |
| Dec 31, 2025 | 448,000.00 |
| Sep 30, 2025 | 216,000.00 |
| Jun 30, 2025 | 383,000.00 |
| Mar 31, 2025 | 134,000.00 |
| Dec 31, 2024 | 132,000.00 |
| Sep 30, 2024 | 184,000.00 |
| Jun 30, 2024 | 69,000.00 |
| Mar 31, 2024 | 66,000.00 |
| Dec 31, 2023 | 83,000.00 |
| Sep 30, 2023 | 564,000.00 |
| Jun 30, 2023 | 240,000.00 |
| Mar 31, 2023 | 150,000.00 |
| Dec 31, 2022 | 17,000.00 |
| Sep 30, 2022 | 413,000.00 |
| Jun 30, 2022 | 109,000.00 |
| Mar 31, 2022 | 199,000.00 |
| Dec 31, 2021 | 166,000.00 |
| Jun 30, 2021 | 1.47 Mn |
| Dec 31, 2020 | 164,000.00 |